Schedule 13G ownership disclosure
Nuvectis Pharma Inc
Security class unavailable · CUSIP: 67080T108
Event date: 2022-03-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.0300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-038947
- Form type
- SC 13G
- Filer
- Mosseri Marlio Charles
- CIK
- CIK 1806384
- Filed
- Mar 29, 2022
- Reporting period
- Mar 22, 2022
- Description
- Schedule 13G beneficial ownership